XML 72 R41.htm IDEA: XBRL DOCUMENT v3.2.0.727
Supplemental Subsidiary Guarantors (Tables) - Supplemental Subsidiary Guarantors
9 Months Ended
Jul. 31, 2015
Condensed Financial Statements, Captions [Line Items]  
Subsidiary guarantor condensed consolidating statements of income
Condensed Consolidating Statement of Income
Quarter ended July 31, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
430,840

 
$
611,006

 
$
(249,663
)
 
$
792,183

Cost of sales

 
320,352

 
448,222

 
(193,736
)
 
574,838

Product development, selling and administrative expenses
12,499

 
63,209

 
69,507

 

 
145,215

Other (income) expense

 
3,771

 
(5,005
)
 

 
(1,234
)
Operating income (loss)
(12,499
)
 
43,508

 
98,282

 
(55,927
)
 
73,364

Intercompany items
16,750

 
(30,145
)
 
(6,865
)
 
20,260

 

Interest (expense) income, net
(16,068
)
 
1,907

 
485

 

 
(13,676
)
Income (loss) before income taxes and equity in income of subsidiaries
(11,817
)
 
15,270

 
91,902

 
(35,667
)
 
59,688

Provision (benefit) for income taxes
(8,654
)
 
997

 
22,460

 

 
14,803

Equity in income of subsidiaries
48,048

 
21,602

 

 
(69,650
)
 

Net income
$
44,885

 
$
35,875

 
$
69,442

 
$
(105,317
)
 
$
44,885

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
13,863

 
$
37,066

 
$
32,532

 
$
(69,598
)
 
$
13,863



Condensed Consolidating Statement of Income
Quarter ended August 1, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
520,247

 
$
564,148

 
$
(208,734
)
 
$
875,661

Cost of sales

 
378,457

 
414,784

 
(169,512
)
 
623,729

Product development, selling and administrative expenses
7,017

 
49,337

 
80,905

 

 
137,259

Other (income) expense

 
2,350

 
(6,968
)
 

 
(4,618
)
Operating income (loss)
(7,017
)
 
90,103

 
75,427

 
(39,222
)
 
119,291

Intercompany items
15,641

 
(14,897
)
 
(7,048
)
 
6,304

 

Interest (expense) income, net
(15,614
)
 
1,055

 
(338
)
 

 
(14,897
)
Income (loss) before income taxes and equity in income of subsidiaries
(6,990
)
 
76,261

 
68,041

 
(32,918
)
 
104,394

Provision (benefit) for income taxes
(5,923
)
 
32,720

 
6,329

 
(21
)
 
33,105

Equity in income of subsidiaries
72,356

 
25,017

 

 
(97,373
)
 

Net income
$
71,289

 
$
68,558

 
$
61,712

 
$
(130,270
)
 
$
71,289

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
81,683

 
$
68,652

 
$
81,173

 
$
(149,825
)
 
$
81,683



Condensed Consolidating Statement of Income
Nine Months ended July 31, 2015
 
 
 
 
 
 
 
 
 
 
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,400,258

 
$
1,616,442

 
$
(710,121
)
 
$
2,306,579

Cost of sales

 
1,026,939

 
1,191,499

 
(543,451
)
 
1,674,987

Product development, selling and administrative expenses
36,503

 
185,949

 
222,119

 

 
444,571

Other (income) expense
68

 
12,872

 
(18,287
)
 

 
(5,347
)
Operating income (loss)
(36,571
)
 
174,498

 
221,111

 
(166,670
)
 
192,368

Intercompany items
50,106

 
(75,362
)
 
(35,306
)
 
60,562

 

Interest (expense) income, net
(47,449
)
 
5,242

 
2,302

 

 
(39,905
)
Income (loss) before income taxes and equity in income of subsidiaries
(33,914
)
 
104,378

 
188,107

 
(106,108
)
 
152,463

Provision (benefit) for income taxes
(2,739
)
 
25,502

 
22,508

 

 
45,271

Equity in income of subsidiaries
138,367

 
18,818

 

 
(157,185
)
 

Net income
$
107,192

 
$
97,694

 
$
165,599

 
$
(263,293
)
 
$
107,192

 
 
 
 
 
 
 
 
 
 
Comprehensive (loss) income
$
(10,567
)
 
$
98,570

 
$
32,065

 
$
(130,635
)
 
$
(10,567
)


Condensed Consolidating Statement of Income
Nine Months ended August 1, 2014
 
 
 
 
 
 
 
 
 
 
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,495,659

 
$
1,803,084

 
$
(654,040
)
 
$
2,644,703

Cost of sales

 
1,108,173

 
1,308,371

 
(537,045
)
 
1,879,499

Product development, selling and administrative expenses
35,840

 
183,363

 
225,619

 

 
444,822

Other (income) expense
(473
)
 
8,890

 
(18,313
)
 

 
(9,896
)
Operating income (loss)
(35,367
)
 
195,233

 
287,407

 
(116,995
)
 
330,278

Intercompany items
48,422

 
(60,625
)
 
(19,053
)
 
31,256

 

Interest (expense) income, net
(47,495
)
 
4,595

 
335

 

 
(42,565
)
Income (loss) before income taxes and equity in income of subsidiaries
(34,440
)
 
139,203

 
268,689

 
(85,739
)
 
287,713

Provision (benefit) for income taxes
(15,855
)
 
89,828

 
19,639

 

 
93,612

Equity in income of subsidiaries
212,686

 
105,984

 

 
(318,670
)
 

Net income
$
194,101

 
$
155,359

 
$
249,050

 
$
(404,409
)
 
$
194,101

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
187,272

 
$
156,753

 
$
243,127

 
$
(399,880
)
 
$
187,272

Subsidiary guarantor condensed consolidating balance sheets
Condensed Consolidating Balance Sheet
As of July 31, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
25,138

 
$
1,972

 
$
113,790

 
$

 
$
140,900

Accounts receivable, net

 
245,241

 
600,477

 
(16,182
)
 
829,536

Inventories

 
561,454

 
721,493

 
(98,605
)
 
1,184,342

Other current assets
72,794

 
13,864

 
90,561

 

 
177,219

Total current assets
97,932

 
822,531

 
1,526,321

 
(114,787
)
 
2,331,997

Property, plant and equipment, net
22,152

 
328,549

 
529,465

 
(5,016
)
 
875,150

Other assets:
 
 
 
 
 
 
 
 
 
Other intangible assets, net

 
214,724

 
117,745

 

 
332,469

Goodwill

 
453,401

 
1,100,776

 

 
1,554,177

Deferred income taxes
2,841

 

 
71,691

 

 
74,532

Other non-current assets
4,095,114

 
1,978,193

 
2,569,176

 
(8,478,679
)
 
163,804

Total other assets
4,097,955

 
2,646,318

 
3,859,388

 
(8,478,679
)
 
2,124,982

Total assets
$
4,218,039

 
$
3,797,398

 
$
5,915,174

 
$
(8,598,482
)
 
$
5,332,129

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$
14,063

 
$

 
$
108

 
$

 
$
14,171

Trade accounts payable
2,273

 
139,552

 
189,013

 

 
330,838

Employee compensation and benefits
4,976

 
31,460

 
46,465

 

 
82,901

Advance payments and progress billings

 
100,564

 
212,375

 
(15,217
)
 
297,722

Accrued warranties

 
21,869

 
34,933

 

 
56,802

Other accrued liabilities
58,613

 
66,386

 
100,545

 
(13,104
)
 
212,440

Current liabilities of discontinued operations

 
11,582

 

 

 
11,582

Total current liabilities
79,925

 
371,413

 
583,439

 
(28,321
)
 
1,006,456

Long-term obligations
1,256,025

 

 
7

 

 
1,256,032

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
17,849

 
872

 

 

 
18,721

Accrued pension costs
117,596

 
8,659

 
9,025

 

 
135,280

Other non-current liabilities
2,377

 
7,343

 
161,653

 

 
171,373

Total other liabilities
137,822

 
16,874

 
170,678

 

 
325,374

Shareholders’ equity
2,744,267

 
3,409,111

 
5,161,050

 
(8,570,161
)
 
2,744,267

Total liabilities and shareholders’ equity
$
4,218,039

 
$
3,797,398

 
$
5,915,174

 
$
(8,598,482
)
 
$
5,332,129



Condensed Consolidating Balance Sheet
As of October 31, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 


Cash and cash equivalents
$
54,874

 
$
16,429

 
$
198,888

 
$

 
$
270,191

Accounts receivable, net

 
391,672

 
684,299

 
(16,262
)
 
1,059,709

Inventories

 
470,194

 
753,922

 
(115,808
)
 
1,108,308

Other current assets
87,945

 
9,520

 
82,671

 
15

 
180,151

Total current assets
142,819

 
887,815

 
1,719,780

 
(132,055
)
 
2,618,359

Property, plant and equipment, net
23,660

 
345,117

 
527,286

 
(3,623
)
 
892,440

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
228,950

 
90,319

 

 
319,269

Goodwill

 
453,374

 
1,063,319

 

 
1,516,693

Deferred income taxes
159

 

 
70,022

 

 
70,181

Other non-current assets
4,191,771

 
2,106,760

 
2,640,582

 
(8,759,069
)
 
180,044

Total other assets
4,191,930

 
2,789,084

 
3,864,242

 
(8,759,069
)
 
2,086,187

Total assets
$
4,358,409

 
$
4,022,016

 
$
6,111,308

 
$
(8,894,747
)
 
$
5,596,986

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$

 
$
11,634

 
$
105

 
$

 
$
11,739

Trade accounts payable
3,134

 
214,603

 
178,208

 

 
395,945

Employee compensation and benefits
11,639

 
58,374

 
66,898

 

 
136,911

Advance payments and progress billings

 
117,768

 
193,165

 
(24,994
)
 
285,939

Accrued warranties

 
17,002

 
50,270

 

 
67,272

Other accrued liabilities
94,097

 
54,523

 
124,244

 
(7,264
)
 
265,600

Current liabilities of discontinued operations

 
11,582

 

 

 
11,582

Total current liabilities
108,870

 
485,486

 
612,890

 
(32,258
)
 
1,174,988

Long-term obligations
1,269,459

 

 
82

 

 
1,269,541

Other liabilities:
 
 
 
 
 
 
 
 
 
Liabilities for postretirement benefits
18,743

 
866

 

 

 
19,609

Accrued pension costs
132,448

 
7,529

 
4,402

 

 
144,379

Other non-current liabilities
(12,108
)
 
7,780

 
151,800

 

 
147,472

Total other liabilities
139,083

 
16,175

 
156,202

 

 
311,460

Shareholders’ equity
2,840,997

 
3,520,355

 
5,342,134

 
(8,862,489
)
 
2,840,997

Total liabilities and shareholders’ equity
$
4,358,409

 
$
4,022,016

 
$
6,111,308

 
$
(8,894,747
)
 
$
5,596,986

Subsidiary guarantor condensed consolidating statements of cash flows
 
Condensed Consolidating Statement of Cash Flows
Nine Months ended July 31, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 
 
Net cash provided by operating activities
$
76,032

 
$
14,392

 
$
78,290

 
$
168,714

Investing Activities:
 
 
 
 
 
 


Acquisition of businesses, net of cash acquired

 

 
(114,353
)
 
(114,353
)
Property, plant and equipment acquired
(141
)
 
(17,429
)
 
(40,251
)
 
(57,821
)
Proceeds from sale of property, plant and equipment
942

 
214

 
2,915

 
4,071

Other investing activities, net
(1,227
)
 

 
1,852

 
625

Net cash used by investing activities
(426
)
 
(17,215
)
 
(149,837
)
 
(167,478
)
Financing Activities:


 


 


 


Common stock issued
2,853

 

 

 
2,853

Dividends paid
(58,456
)
 

 

 
(58,456
)
Treasury stock purchased
(50,000
)
 

 

 
(50,000
)
Repayments of short-term debt


 
(11,634
)
 
89

 
(11,545
)
Other financing activities, net
261

 

 

 
261

Net cash (used) provided by financing activities
(105,342
)
 
(11,634
)
 
89

 
(116,887
)
Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

 
(13,640
)
 
(13,640
)
(Decrease) Increase in Cash and Cash Equivalents
(29,736
)

(14,457
)

(85,098
)

(129,291
)
Cash and Cash Equivalents at Beginning of Period
54,874

 
16,429

 
198,888

 
270,191

Cash and Cash Equivalents at End of Period
$
25,138

 
$
1,972

 
$
113,790

 
$
140,900



Condensed Consolidating Statement of Cash Flows
Nine Months ended August 1, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 
 
Net cash provided (used) by operating activities of continuing operations
$
194,291

 
$
(4,062
)
 
$
108,092

 
$
298,321

Net cash used by operating activities of discontinued operations

 
(103
)
 

 
(103
)
Net cash provided (used) by operating activities
194,291

 
(4,165
)
 
108,092

 
298,218

Investing Activities:
 
 
 
 
 
 
 
Acquisition of businesses, net of cash acquired

 

 
(47,058
)
 
(47,058
)
Property, plant and equipment acquired
(3,969
)
 
(15,317
)
 
(49,782
)
 
(69,068
)
Proceeds from sale of property, plant and equipment

 
7,124

 
1,758

 
8,882

Other investing activities, net
(82
)
 
232

 
(239
)
 
(89
)
Net cash used by investing activities
(4,051
)
 
(7,961
)
 
(95,321
)
 
(107,333
)
Financing Activities:


 


 


 


Common stock issued
10,189

 

 

 
10,189

Dividends paid
(55,334
)
 

 

 
(55,334
)
Repayments of term loan
(37,500
)
 

 

 
(37,500
)
Treasury stock purchased
(194,336
)
 

 

 
(194,336
)
Repayments of short term debt


 


 


 

Other financing activities, net
(1,099
)
 
(1,212
)
 
(8,008
)
 
(10,319
)
Net cash used by financing activities
(278,080
)
 
(1,212
)
 
(8,008
)
 
(287,300
)
Effect of Exchange Rate Changes on Cash and Cash Equivalents

 

 
(1,252
)
 
(1,252
)
(Decrease) Increase in Cash and Cash Equivalents
(87,840
)
 
(13,338
)
 
3,511

 
(97,667
)
Cash and Cash Equivalents at Beginning of Period
122,901

 
20,361

 
262,447

 
405,709

Cash and Cash Equivalents at End of Period
$
35,061

 
$
7,023

 
$
265,958

 
$
308,042